High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$12.2M
$12,232,987
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-03-31 | $1,464,474Large | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-03-31 | $493,794 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-03-31 | $12,254 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-12 | $293,707 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-12 | $235,932 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Other
|
2025-11-21 | $13,004 | M | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Congleton Jon
• CEO
Discretionary Sell
2025-11-11
$1,320,165Large
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-11 | $1,320,165Large | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Congleton Jon
• CEO
Discretionary SellΔOwn -14.5%
2025-11-11
$5,145,956Whale
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary SellΔOwn -14.5%
|
2025-11-11 | $5,145,956Whale | S | Form 4 |
|
MLYS
S
Mineralys Therapeutics, Inc.
Congleton Jon
• CEO
Discretionary Sell
2025-11-11
$1,540,212Large
|
||||||
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-11 | $1,540,212Large | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-11 | $173,984 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-11 | $374,947 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
Discretionary Sell
|
2025-11-11 | $533,235 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-13 | $66,782 | S | Form 4 |
| MLYS |
Mineralys Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-10-13 | $577,544 | S | Form 4 |